Close



Nov 7, 2017 06:00AM
Oct 10, 2017 07:00AM
Sep 26, 2017 07:00AM
Sep 11, 2017 04:01PM
Jul 18, 2017 07:00AM
Jul 10, 2017 04:10PM
Jul 10, 2017 04:01PM pSivida Out-licenses EMEA Rights for Durasert™ Three-year Treatment for Posterior Segment Uveitis While Retaining U.S. Commercial Rights; Amended Global Collaboration Agreement with Alimera for ILUV
Jun 28, 2017 07:00AM
Jun 22, 2017 07:02AM
Jun 22, 2017 07:00AM
Jun 13, 2017 07:03AM
Jun 13, 2017 07:00AM
May 8, 2017 09:17AM
May 8, 2017 09:15AM Durasert™ Three-year Treatment for Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months
May 4, 2017 04:01PM
Apr 19, 2017 04:01PM
Mar 15, 2017 07:11AM
Mar 15, 2017 07:00AM
Feb 7, 2017 04:01PM
Jan 25, 2017 07:00AM
Nov 7, 2016 04:15PM Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial Development
Nov 7, 2016 04:01PM
Oct 31, 2016 07:00AM
Oct 4, 2016 07:04AM
Oct 4, 2016 07:00AM
Sep 27, 2016 07:08AM
Sep 27, 2016 07:00AM
Sep 15, 2016 07:07AM pSivida (PSDV) Makes Leadership Changes, Including New CEO Appointment
Sep 15, 2016 07:00AM
Sep 12, 2016 04:01PM
Aug 29, 2016 10:01AM
Aug 29, 2016 10:00AM
Aug 15, 2016 09:06AM
Aug 15, 2016 09:00AM
Aug 9, 2016 10:01AM pSivida (PSDV) Says Medidur Inserter Utilization Study with Smaller-Diameter Needle Met Primary Endpoint
Aug 9, 2016 10:00AM
Aug 3, 2016 08:14AM
Aug 3, 2016 08:00AM
Aug 1, 2016 07:00AM
Jul 27, 2016 07:35AM
Jul 27, 2016 07:30AM
Jul 20, 2016 08:04AM pSivida (PSDV) Announces Presentation of New Tethadur bioerodible Tech Data; Retained High Activity Noted
Jul 20, 2016 08:00AM
Jul 15, 2016 08:03AM
Jul 15, 2016 08:00AM
Jul 14, 2016 11:10AM
Jul 14, 2016 11:00AM
Jul 8, 2016 08:29AM
Jul 5, 2016 08:02AM pSivida (PSDV) Completes Two Preclinical Studies Utilizing Durasert Technology
Jul 5, 2016 08:00AM

377,433 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All